Article

A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19

2022-01-26

Abstract excerpt

Drug repurposing is a more inexpensive and shorter approach than the traditional drug discovery and development process. The concept of identifying a potent molecule from a library of pre-existing molecules or an already approved drug has become a go-to tactic to accelerate the identification of drugs that can prevent COVID-19. This seemingly uncontrollable disease is caused by SARS-CoV-2. It is a novel virus of t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8a13bb0b-f0e7-5a12-88b3-edf8cc92fcec
DOI: 10.3390/covid2020011

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19DOI 10.3390/covid2020011Read

Repurposing drugs for treatment of SARS-CoV-2 infection: Computational design insights into mechanisms of actionSemantic proximity Read

Drug repurposing for SARS-CoV-2: a high-throughput molecular docking, molecular dynamics, machine learning, and DFT studySemantic proximity Read

Systematic Down-Selection of Repurposed Drug Candidates for COVID-19Semantic proximity Read

Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19Semantic proximity Read

Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico MethodSemantic proximity Read

An Overview of SARS-CoV-2 Potential Targets, Inhibitors, and Computational Insights to Enrich the Promising Treatment StrategiesSemantic proximity Read

In Silico Drug Discovery: The Next Frontier in the Fight Against SARS-CoV-2Semantic proximity Read

Identification of drugs targeting multiple viral and human proteins using computational analysis for repurposing against COVID-19Semantic proximity Read

Repurposing FDA-approved drugs against the “main protease” pivotal enzyme in COVID-19 virus using computer-aided drug design techniquesSemantic proximity Read

Integrated Docking and Enhanced Sampling Based Selection of Repurposing Drugs for SARS-CoV-2 by Targeting Host Dependent FactorsSemantic proximity Read

Virtual Screening Based Prediction of Potential Drugs for COVID-19Semantic proximity Read

Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studiesSemantic proximity Read